Overview

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to establish the efficacy, safety and tolerability of rosuvastatin in children and adolescents with homozygous familial hypercholesterolemia.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Rosuvastatin Calcium